Respironics licenses obstructive sleep apnoea (OSA) treatment technology:
This article was originally published in Clinica
Executive Summary
DeVilbiss Health Care (US) will utilise Respironics' patented bi-level airway pressure technology under the terms of a North American licensing agreement announced by the two companies in January. Respironics will receive royalties on sales of DeVilbiss products incorporating the obstructive sleep apnoea (OSA) treatment technology, for which patents were awarded in July 1995. Respironics recently filed a patent infringement suit against AirSep, which had announced its intention to market a bi-level device that Respironics believes is "a clear violation" of its patents in the sector.